Shortness Of Breath in Lung Cancer

Conditions

Intrathoracic cancer Cancer Intrathoracic cancer

Johnson MJ, Kanaan M, Richardson G, Nabb S, Torgerson D, English A, Barton R, Booth S.

2015-09-0738 citations

Randomized trial of high- versus low-intensity breathing training for dyspnea due to intrathoracic cancer: Cost-effectiveness.

Miriam J. Johnson, Mona Kanaan, Gerry Richardson, Sam Nabb, Rachael Barton et al. (7 authors)

Journal of Clinical Oncology2014-11-012 citations

10.1200/jco.2014.32.31_suppl.54

Interventions

Patients randomised to the single session training arm will be taught the four techniques of management of breathlessness (breathing control, pacing, anxiety management and relaxation) at a single ses

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Primary or secondary malignant lung disease 2. Aged over 18 years 3. Willingness to engage with breathlessness training 4. Ability to give informed consent 5. Sufficient understanding of the English language to complete the study questionnaires 6. Severity average breathlessness (Numeric Rating Scale [NRS]) greater than 3 7. All identified reversible causes of the breathlessness have been treated if appropriate to do so, in the opinion of the attending clinician 8. Verbal confirmation of consent 9. Estimated prognosis (in the investigator's opinion) of greater than 3 months

Exclusion criteria

Exclusion criteria: 1. Inability to give informed consent 2. Intercurrent illness or co-morbidities making completion of the study unlikely 3. Rapidly worsening breathlessness requiring urgent medical intervention 4. Insufficient understanding of the English language to complete the study questionnaires 5. Verbal withdrawal of consent 6. Unable to complete study assessments

Design outcomes

Primary

Measure	Time frame
Worst severity of breathlessness over past 24 hours measured by NRS	—

Secondary

Measure	Time frame
1. Breathlessness score on NRS (severity: average over last 24 hours) 2. NRS distress from breathlessness 3. NRS satisfaction with care of breathlessness 4. Global impression of changes of breathlessness 5. CRQ-SAS 6. HADS 7. Brief COPE/NRS cope 8. EQ5D 9. CIEQ-Chr 10. Number of other interventions for breathlessness during study period 11. Number of hospital admissions during study period 12. Costs associated with both comparators 13. Correlation with baseline BFI, MTQ, CIEQ-Chr scores 14. Correlation with patient programme preference The following are measured at all time points: breathlessness severity (average over past 24 hours); distress due to, coping with, and satisfaction with the management of breathlessness; EQ5D. All secondary endpoints are measured at weeks 4 and 8 except for the global impression of change of breathlessness which is only measured at week 4.	—

Measure

Time frame

1. Breathlessness score on NRS (severity: average over last 24 hours) 2. NRS distress from breathlessness 3. NRS satisfaction with care of breathlessness 4. Global impression of changes of breathlessness 5. CRQ-SAS 6. HADS 7. Brief COPE/NRS cope 8. EQ5D 9. CIEQ-Chr 10. Number of other interventions for breathlessness during study period 11. Number of hospital admissions during study period 12. Costs associated with both comparators 13. Correlation with baseline BFI, MTQ, CIEQ-Chr scores 14. Correlation with patient programme preference The following are measured at all time points: breathlessness severity (average over past 24 hours); distress due to, coping with, and satisfaction with the management of breathlessness; EQ5D. All secondary endpoints are measured at weeks 4 and 8 except for the global impression of change of breathlessness which is only measured at week 4.

—

Countries

England, United Kingdom

Outcome results

None listed